Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS
NA
liver cirrhosis
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
Management of chronic hepatitis C (CHC) has significantly accelerated in the last few years. Currently, second generation direct acting antivirals (DAAs) promise clearance of infection in most of patients. Here we present the results of the first analysis carried out on data of Lazio clinical network for DAAs.
HCC in cirrhotic and non-cirrhotic liver: timing to surgery and outcome. State of the art
In this chapter we aim at presenting status of art in Liver Surgery. After a brief introduction about natural evolution of HCC either in cirrhotic and non-cirrhotic patients, this manuscript will focus on planning and timing surgery: CT evaluation of remnant liver, biopsy and US evaluation of liver disease, intra-operative US, surgical techniques, such as major and limited hepatectomies, two-stage hepatectomies, each of them in open or mini-invasive approach, and their possible complications. Follow-up and further interventions during expected recurrences will be highlighted.